Titan Pharmaceuticals
TTNP
#10393
Rank
โ‚น0.55 B
Marketcap
โ‚น419.70
Share price
-3.76%
Change (1 day)
27.42%
Change (1 year)

EPS for Titan Pharmaceuticals (TTNP)

EPS in 2025 (TTM): -โ‚น369.19

According to Titan Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is -โ‚น399.67. In 2023 the company made an earnings per share (EPS) of -โ‚น674.61 an increase over its 2022 EPS that were of -โ‚น1,383.

EPS history for Titan Pharmaceuticals from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น369.19
2023-โ‚น674.61-51.22%
2022-โ‚น1,383-15.61%
2021-โ‚น1,639-81.37%
2020-โ‚น8,795-77.52%
2019-โ‚น39,129-56.32%
2018-โ‚น89,585-59.51%
2017-โ‚น2,21,276-371.81%
2016โ‚น81,408-144.35%
2015-โ‚น1,83,540300%
2014-โ‚น45,885-121.54%
2013โ‚น2,13,038-151.38%
2012-โ‚น4,14,605-11.54%
2011-โ‚น4,68,684188.89%
2010-โ‚น1,62,237-10%
2009-โ‚น1,80,263
2007-โ‚น7,39,078-2.38%
2006-โ‚น7,57,105-39.13%
2005-โ‚น12,43,815-16.87%
2004-โ‚น14,96,183-22.43%
2003-โ‚น19,28,8144.9%
2002-โ‚น18,38,68361.9%
2001-โ‚น11,35,657-13.7%
2000-โ‚น13,15,92065.01%
1999-โ‚น7,97,492-35.87%
1998-โ‚น12,43,603-1824.71%
1997โ‚น72,105-102.4%
1996-โ‚น30,10,392

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,014-353.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚น670.06-267.65%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vanda Pharmaceuticals
VNDA
-โ‚น129.28-67.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
โ‚น2.73-100.68%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-โ‚น22.76-94.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-โ‚น307.72-23.01%๐Ÿ‡บ๐Ÿ‡ธ USA